<DOC>
<DOCNO>
EP-0005051
</DOCNO>
<TEXT>
<DATE>
19791031
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/475 C07D-519/00 A61K-31/435 C07D-519/04 A61K-31/44 <main>C07D-519/04</main> A61P-35/00 
</IPC-CLASSIFICATIONS>
<TITLE>
4-desacetyl vlb c-3 carboxhydrazides, their preparation and formulations containing them.
</TITLE>
<APPLICANT>
lilly co elius<sep>eli lilly and company  <sep>eli lilly and company307, east mccarty streetindianapolis indiana 46285us<sep>eli lilly and company<sep>
</APPLICANT>
<INVENTOR>
cullinan george joseph<sep>gerzon koert<sep>cullinan, george joseph<sep>gerzon, koert<sep>cullinan, george josephr.r.1. box 124btrafalgar indiana 46181us<sep>gerzon, koert61, kessler boulevard east driveindianapolis indiana 46220us<sep>cullinan, george joseph  <sep>gerzon, koert<sep>cullinan, george josephr.r.1. box 124btrafalgar indiana 46181us<sep>gerzon, koert61, kessler boulevard east driveindianapolis indiana 46220us<sep>
</INVENTOR>
<ABSTRACT>
4-desacetyl vincaleucoblastine c-3 carboxhydrazides of  the formula    wherein q is    r is, when taken singly, c₁-c₃ alkyl, β-hydroxyethyl,  β-acetoxyethyl, c₂-c₄ alkanoyl, dichloroacetyl,  benzoyl or c₁-c₃ alkyl carbazyl;   r¹ is, when taken singly, methyl or h only when r is  c₁-c₃ alkyl and is h otherwise; and   r and r¹, when taken together, form a c₁-c₃ alkylidene  group.  the compounds are prepared by reacting the c-3  carboxazides with    or by reacting the unsubstituted c-3 carboxhydrazide with  acetone or with the appropriate aldehyde, acid anhydride or  acid chloride.  the compounds are useful in inhibiting the growth of  tumors.  
</ABSTRACT>
</TEXT>
</DOC>
